VRS
ABUS icon

Virginia Retirement Systems’s Arbutus Biopharma ABUS Stock Holding History

Virginia Retirement Systems’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+41,800
New +$184K ﹤0.01% 1260
2026
Q1 		– Sell
-20,500
Closed -$98.6K – 928
2025
Q4 		$98.6K Sell
20,500
-700
-3% -$3.15K ﹤0.01% 942
2025
Q3 		$96.2K Sell
21,200
-15,100
-42% -$55.5K ﹤0.01% 922
2025
Q2 		$112K Sell
36,300
-3,300
-8% -$11K ﹤0.01% 925
2025
Q1 		$138K Buy
+39,600
New +$132K ﹤0.01% 985

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Virginia Retirement Systems's ABUS Position: Q2 2026 in Review

Virginia Retirement Systems opened a new position in Arbutus Biopharma (ABUS) in Q2 2026: 41,800 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #1260 among its holdings. This is a return to the name: Virginia Retirement Systems previously reported a position in ABUS as recently as Q4 2025.

Virginia Retirement Systems first reported a position in ABUS in Q1 2025 and has held it in 5 quarters since. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • Virginia Retirement Systems held 41,800 shares of Arbutus Biopharma worth $201K as of Q2 2026.
  • Arbutus Biopharma was a new Virginia Retirement Systems position in Q2 2026.
  • Arbutus Biopharma made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #1260 holding.
  • Virginia Retirement Systems first reported a position in Arbutus Biopharma in Q1 2025 and has held it in 5 quarters since.
  • 176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.